Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01297101 |
|
Recruitment Status
:
Temporarily not available
First Posted
: February 16, 2011
Last Update Posted
: February 16, 2011
|
Sponsor:
Shanghai Chest Hospital
Collaborators:
Guangdong General Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Information provided by:
Shanghai Chest Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Temporarily not available |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | No date given |